December 12, 2024 21:49 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
UP teenager kills mother, lives with body for 5 days | At least six people including a child killed in Tamil Nadu hospital fire | Amid Atul Subhash row, SC says mere harassment is not enough to prove abetment to suicide | India's D Gukesh becomes youngest ever world champion in chess | Devendra Fadnavis meets PM Modi amid suspense over Maharashtra portfolio allocation | Congress wants to deviate the issue of Sonia Gandhi-George Soros link: JP Nadda | Bengaluru techie suicide: Atul Subhash's family demanded Rs. 10 lakh as dowry leading to my father's death, claims estranged wife | Syria rebels torch tomb of ousted president Bashar al-Assad's father | Donald Trump vows to eliminate birthright citizenship after taking charge | No alliance with Congress in Delhi polls: AAP chief Arvind Kejriwal
Bharat Biotech’s intra-nasal Covid-19 vaccine receives approval for emergency use in India

Bharat Biotech’s intra-nasal Covid-19 vaccine receives approval for emergency use in India

Sep 07, 2022, at 01:37 am

Hyderabad/UNI: Bharat Biotech International Limited (BBIL) Tuesday announced that iNCOVACC (BBV154), its intra-nasal vaccine against Covid-19, has received approval under restricted use in an emergency situation for ages 18 and above in India.